Nuclear factor (erythroid-derived 2)-like-2 pathway modulates substance P–induced human mast cell activation and degranulation in the hair follicle  Laura.

Slides:



Advertisements
Similar presentations
Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M
Advertisements

TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis  Maya Zimmermann, PhD, Andrea Koreck, MD, Norbert.
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD  Rubaiyat Haque, MBBS,
Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition  Iain S. Haslam, Laura.
The importance of being “pure” neutrophils
Pharmacological inhibition of caspase-8 suppresses inflammation-induced lymphangiogenesis and allograft rejection in the cornea  Wenru Su, MD, PhD, Longhui.
Modulation of basophil activity: A novel function of the neuropeptide α-melanocyte– stimulating hormone  Markus Böhm, MD, Mara Apel, Koji Sugawara, MD,
Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated.
Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI  Tanya M. Laidlaw, MD, John W. Steinke,
Akos Heinemann, MD, Gunter J. Sturm, MD, Martina Ofner, BSc, Eva M
IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven TH1 differentiation  Regina K. Rowe, MD, PhD, David M. Pyle, MD,
Activation of protease-activated receptor 2 leads to impairment of keratinocyte tight junction integrity  Peter Nadeau, BS, Mason Henehan, BS, Anna De.
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,
IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis  Norbert Meyer, MD, Maya Zimmermann, PhD,
Siglec-7 is an inhibitory receptor on human mast cells and basophils
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization  Silvia.
Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells  Jun Young Hong, MS, J. Kelley.
Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA  Hirokazu Kinoshita, MD,
D prostanoid receptor 2 (chemoattractant receptor–homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects.
Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with β2-adrenergic agonists  Elena Goleva, PhD, Annegret.
Human mast cells arise from a common circulating progenitor
Pharmacologic inhibition of Notch signaling suppresses food antigen–induced mucosal mast cell hyperplasia  Asuka Honjo, MD, Nobuhiro Nakano, PhD, Susumu.
Functional analysis of protective IL1RL1 variants associated with asthma risk  Vladimir Ramirez-Carrozzi, PhD, Amy Dressen, MS, Patrick Lupardus, PhD,
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps  Can Altunbulakli, MSc, Rita Costa,
Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes  Mu Xian, MD, PhD, Paulina Wawrzyniak,
Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α  John T. Schroeder, PhD,
Toluene downregulates filaggrin expression via the extracellular signal-regulated kinase and signal transducer and activator of transcription–dependent.
TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis  Maya Zimmermann, PhD, Andrea Koreck, MD, Norbert.
Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B- cell dysfunction in patients with Smith-Magenis syndrome  Javier Chinen,
Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma  Po-Jui Chang, MD, Pankaj K. Bhavsar, PhD,
Dexamethasone regulation of thymic stromal lymphopoietin receptor expression on mast cells and their precursors  Zoulfia Allakhverdi, PhD, Michael R.
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis  Bodi.
Katherine G. MacDonald, BSc, Nicholas A. J
David M. Pyle, BS, Victoria S. Yang, MD, Rebecca S
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype  Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
Asthma predisposition and respiratory syncytial virus infection modulate transient receptor potential vanilloid 1 function in children's airways  Terri.
Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: Important implications in asthma  Fei Huang, PhD, Shinichiro Wachi, PhD,
Renee Rawson, BS, Tom Yang, BS, Robert O
Fibronectin is a TH1-specific molecule in human subjects
Activin A is an acute allergen-responsive cytokine and provides a link to TGF-β– mediated airway remodeling in asthma  Christian Karagiannidis, MD, Gabriele.
A thymic stromal lymphopoietin–responsive dendritic cell subset mediates allergic responses in the upper airway mucosa  Guro R. Melum, MD, Lorant Farkas,
Antiviral activity of human β-defensin 3 against vaccinia virus
Zoulfia Allakhverdi, PhD, Michael R. Comeau, BSc, Dirk E
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis  Deepti R. Nagarkar, PhD, Julie A. Poposki,
Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin  Deepti R. Nagarkar, PhD, Julie A.
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease  Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,
Fibronectin is a TH1-specific molecule in human subjects
Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk  Luzheng Xue, PhD, Joannah Fergusson,
Enhanced CD46-induced regulatory T cells suppress allergic inflammation after Dermatophagoides pteronyssinus–specific immunotherapy  Yi-Giien Tsai, MD,
Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell–dependent manner through cysteinyl leukotriene.
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts  Séverine Létuvé, PhD, Stéphane Lajoie-Kadoch, MSc, Séverine Audusseau,
TGF-β1–induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis  Lisa Y. Beppu, BS,
MicroRNA-4443 regulates mast cell activation by T cell–derived microvesicles  Irit Shefler, PhD, Pazit Salamon, PhD, Francesca Levi-Schaffer, PharmD, Adam.
Activation of human mast cells through the platelet-activating factor receptor  Naoki Kajiwara, PhD, Tomomi Sasaki, BSc, Peter Bradding, DM, Glenn Cruse,
Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes  Mu Xian, MD, PhD, Paulina Wawrzyniak,
Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease  Xin Feng, MD, Madison K. Ramsden, BS, Julie Negri,
Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma 
The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells  Zuyi Weng, MS, PhD, Arti B. Patel, MS, Smaro Panagiotidou, MA, Theoharis.
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Regulation of IL-13 receptor α1 expression and signaling on human tonsillar B- lymphocyte subsets  Oumnia Hajoui, PhD, Huaien Zheng, MD, PhD, Julie Guay,
Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking  Viktoria Konya, PhD, Andreas Üllen, PhD, Nora Kampitsch,
Nrf2 activation by sulforaphane restores the age-related decrease of TH1 immunity: Role of dendritic cells  Hyon-Jeen Kim, PhD, Berenice Barajas, BS,
Human newborn B cells mount an interferon-α/β receptor-dependent humoral response to respiratory syncytial virus  Jop Jans, MD, Matthew Pettengill, PhD,
Alexander S. Kim, MD, Taylor A. Doherty, MD, Maya R
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin  Soma.
Presentation transcript:

Nuclear factor (erythroid-derived 2)-like-2 pathway modulates substance P–induced human mast cell activation and degranulation in the hair follicle  Laura Jadkauskaite, BSc, PhD, Rajia Bahri, BSc, PhD, Nilofer Farjo, MB, ChB, BAO, LRCPSI, Bessam Farjo, MB, ChB, BAO, LRCPSI, Gail Jenkins, BSc, PhD, Ranjit Bhogal, BSc, PhD, Iain Haslam, BSc, PhD, Silvia Bulfone-Paus, MD, PhD, Ralf Paus, MD, FRSB  Journal of Allergy and Clinical Immunology  Volume 142, Issue 4, Pages 1331-1333.e8 (October 2018) DOI: 10.1016/j.jaci.2018.04.039 Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Nrf2 activity within human MCs. A, Nrf2 and MCT immunofluorescent staining in isolated human HFs. MCT+ cells (green) showed low expression of Nrf2 immunofluorescence (red) with infrequent Nrf2/MCT double-positive immunofluorescence. B, The number of Nrf2/MCT double-positive cells did not increase after 2 and 4 hours (the graph presents combined 2-hour and 4-hour treatment of SFN). C and D, Treatment with SFN and SP significantly increased expression of MCT/HO-1 double-positive cells. MCT (purple) detected in the CTS and HO-1 (red) activity was found in the HF epithelium and vasculature of CTS. (n = 3 donors; data are mean ± SEM; 1-way ANOVA; significance indicated by *P < .05; **P < .01; ***P < .001). E and F, Expression of phoshoprylated nuclear Nrf2 (red) in human primary MCs is increased after treatment with SFN (n = 3 donors; ± SD). HO-1 (G), NQO1 (H), and IL-1β (I) in PBDMCs were measured by quantitative RT-PCR and data reported as fold changes in normalized expression (n = 8 donors; data are mean ± SEM; 1-way ANOVA; significance indicated by *P < .05; **P < .01; ***P < .001). DAPI, 4′-6-Diamidino-2-phenylindole, dihydrochloride; NQO1, NADP(H) dehydrogenase-quinone 1. Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Stimulation with SP induces MC degranulation and upregulates secretion of mediators. A, Gating strategy identifying expression of CD107a and CD63 in PBDMCs. B and C, Decrease in CD63 and CD107a PBDMCs after pretreatment with SFN. D, Pretreatment with SP suppressed SP-induced β-hexosaminidase release (n = 7 donors; data are mean ± SEM; paired t test; significance indicated by *P < .05). E and F, Secretion of lipid derivatives after treatment with SFN and SP (n = 4-5 donors; data are mean ± SEM; 1-way ANOVA; significance indicated by *P < .05). G-I, Toluidine blue staining indicated MCs degranulation and number within CTS of human HFs (n = 3 donors; data are mean ± SEM; 1-way ANOVA; significance indicated by *P < .05; **P < .01; ***P < .001). Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 LAD2 cells were treated with SFN to measure nuclear (DAPI) Nrf2 (green) translocation. In both, control and SFN conditions, the expression of Nrf2 (green) was cytoplasmic, with no nuclear detection (DAPI). DAPI, 4′-6-Diamidino-2-phenylindole, dihydrochloride. Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Expression of MC target genes in PBDMCs. A, Expression of CD69 mRNA in PBDMCs did not change after treatment with SFN or SP. B, The mRNA levels of TNF-α were increased after pretreatment with SFN before SP (n = 8 donors; data are mean ± SEM; 1-way ANOVA; significant indicate by *P < .05). Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 The expression of Nrf2 and MCs target genes in human LAD2. HO-1 (A), NQO1 (B), CD69 (C), and IL-1β (D) in LAD2 were measured by quantitative RT-PCR and data reported as fold changes in normalized expression (n = 9 repeats; data are mean ± SEM; 1-way ANOVA; significance indicated by *P < .05; **P < .01; ***P < .001). NQO1, NADP(H) dehydrogenase-quinone 1. Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 LAD2 degranulation after treatment with SP and SFN (1 hour). A, SP alone increased CD63 expression on LAD2 surface. Pretreatment with SFN did not reduce SP-induced activity. B, Treatment with SP induced CD107a expression on LAD2, but SFN pretreatment did not have an effect against SP. C, Pretreatment with SFN before SP exposure did not reduce release of β-hexosaminidase (n = 3-4 repeats; data are mean ± SEM). Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E5 PBDMCs degranulation after treatment with SFN (24 hours) and SP (1 hour). The expression of both MC degranulation markers (A), CD63 (B), and CD107a (C) was not reduced after pretreatment with SFN for 24 hours (n = 4 donors; data are mean ± SEM). FSC-A, Forward scatter-area. Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E6 Measurement of secretion of PGD2 and PGE2 and mRNA levels of PTGDS and PTGES in PBDMCs. A, Pretreatment with SFN for 24 hours reduced SP-induced PGD2 release. B, Stimulation with SFN for 24 hours had a minimal suppression effect of PGE2 release during SP exposure. (n = 4 donors; data are mean ± SEM; 1-way ANOVA; significance indicated by **P < .01). C, The expression of PTGD mRNA was not affected by SFN and SP treatment. D, The PTGE mRNA levels were variable between 2 donors and no effect of SP and SFN was observed. (n = 2-5 donors; data are mean ± SD). Journal of Allergy and Clinical Immunology 2018 142, 1331-1333.e8DOI: (10.1016/j.jaci.2018.04.039) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions